Search Within

Saad Zafar Usmani

Formats
  1. Meeting Abstract (196)
  2. Journal Article (66)
  3. Review (14)
  4. Research Letter (9)
  5. Correspondence (4)
  6. Editorial (4)
  7. Guidelines (2)
  8. Book Section (1)
Groups
  1. Hematologic Malignancies, Division of (143)
  2. Department of Medicine (142)
  3. Center for Hematologic Malignancies (139)
  4. Myeloma (131)
  5. Graduate Medical Education (129)
  6. GME, Medicine (120)

More Groups

People
  1. Alexander Lesokhin (114)
  2. Kylee Maclachlan (109)
  3. Sham Mailankody (99)
  4. Urvi Shah (99)
  5. Carlyn Rose Tan (93)
  6. Malin Hultcrantz (91)

More People

Years
  1. 2025 (15)
  2. 2024 (75)
  3. 2023 (123)
  4. 2022 (83)
Publications
  1. Blood (86)
  2. Clinical Lymphoma, Myeloma and Leukemia (79)
  3. Journal of Clinical Oncology (30)
  4. Blood Cancer Journal (14)
  5. Blood Advances (13)
  6. Oncology Research and Treatment (7)

More Publications

Publishers
  1. American Society of Hematology (99)
  2. Elsevier Inc. (91)
  3. American Society of Clinical Oncology (30)
  4. Nature Publishing Group (20)
  5. Elsevier Science, Inc. (10)
  6. S. Karger AG (7)

More Publishers

Results (296)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Daratumumab (DARA) + lenalidomide/bortezomib/dexamethasone (RVd) in Black patients with transplant-eligible newly diagnosed multiple myeloma (NDMM): An updated subgroup analysis of GRIFFIN
    Meeting Abstract

    Nooka, A.; Kaufman, J.; Rodriguez, C.; Jakubowiak, A.; Efebera, Y.; Reeves, B.; Wildes, T.; Holstein, S.; Anderson, L.; Badros, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen
    Meeting Abstract

    Meseha, M.; Abusamra, M.; Farooki, A.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Shah, U.; Lu, S.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Prognostic utility of the evolving biomarker-based progression model (e-model) for smoldering multiple myeloma (SMM) in a diverse population
    Meeting Abstract

    Atrash, S.; Robinson, M.; Cassetta, K.; Varga, C.; Pineda-Roman, M.; Friend, R.; Paul, B.; Usmani, S.; Luong, V.; Voorhees, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Network topology analysis reveals unique multiple myeloma genomic subtypes and potential new therapeutic targets
    Meeting Abstract

    Simhal, A.; Maclachlan, K.; Elkin, R.; Zhu, J.; Usmani, S.; Deasy, J. O.; Oh, J. H.; Tannenbaum, A.
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker for multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • African American patients with smoldering multiple myeloma may have a lower risk of progression compared to white patients
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: A retrospective study of 34 patients highlighting the need for consensus criteria
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Derkach, A.; Jaffer-Sathick, I.; Rossi, A.; Salvatore, S.; Landau, H.; Lahoud, O.; Korde, N.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Pathogenic germline mutations in a large cohort of multiple myeloma
    Meeting Abstract

    Conry, M.; Camp, N.; Vachon, C.; Slager, S.; Hildebrandt, M.; Brown, E.; Garber, J.; Norman, A.; Stokes, S.; Lipkin, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Maintenance therapy cessation for patients with three-year sustained MRD negative remissions: Initial results from a phase II study
    Meeting Abstract

    Korde, N.; Diamond, B.; Burge, M.; Hassoun, H.; Landau, H.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save